Stock 66J AMNIOTICS AB
Add to a list
To use this feature you must be a member
Log inSign up

News Amniotics AB Deutsche Boerse AG

Equities

66J

SE0015961016

Delayed Deutsche Boerse AG
Other stock markets
 02:07:08 2024-05-30 EDT 		5-day change 1st Jan Change
0.0001 EUR 0.00% Intraday chart for Amniotics AB -50.00% -50.00%
03-22 Magle Chemoswed Holding AB (OM:MAGLE) made a tender to acquire 99.96% stake in Amniotics AB (OM:AMNI) from LSCS Invest AB, Deflexum AB, Marcus Larsson and other for SEK 10.9 million. CI
02-22 Amniotics AB Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Amniotics secures continued short-term capital needs by extending loan agreement and continued services under service agreement
AQ
Magle Group will not complete the public offer to the shareholders of Amniotics
AQ
MAGLE GROUP REPORTS OUTCOME AND EXTENDS THE ACCEPTANCE PERIOD FOR THE PUBLIC TENDER OFFER TO THE SHAREHOLDERS OF AMNIOTICS
AQ
Magle Chemoswed Q1 - Expansion by acquisition
AQ
Magle Chemoswed Holding AB publishes offer document and announces updated timetable regarding the cash offer to the shareholders of Amniotics AB
AQ
Magle Chemoswed Holding AB (publ) withdraws dividend proposal and enters into term loan facilities amounting to SEK 12 million in total
AQ
Statement from the Board of Directors of Amniotics regarding the public offer from Magle Chemoswed
AQ
Magle Chemoswed Holding AB announces a recommended cash offer of SEK 0.004 per share to the shareholders of Amniotics AB
AQ
Magle Chemoswed Holding AB (OM:MAGLE) made a tender to acquire 99.96% stake in Amniotics AB (OM:AMNI) from LSCS Invest AB, Deflexum AB, Marcus Larsson and other for SEK 10.9 million.
CI
Amniotics secures short-term capital needs by extending loan agreement and entering into a service agreement
AQ
Amniotics announces the outcome of the exercise of warrants series TO 3
AQ
The exercise period for warrants series TO 3 in Amniotics begins today
AQ
Amniotics Q4 2023 - Investigator-sponsored trial in lung transplantation needs funding
AQ
Amniotics AB (publ) Report for the fourth quarter 2023.
AQ
Amniotics AB Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Amniotics AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023
CI
Information about the Annual General Meeting and appointed Nomination Committee of Amniotics
AQ
Amniotics Secures Orphan Designation for Lung Injury Therapy from European Commission
MT
Amniotics receives orphan designation for PulmoStem® from the European Commission for the Treatment of Primary Graft Dysfunction following Lung Transplantation
AQ
Amniotics Q3 2023 - Rights Issue Foundation for Lung Transplantation Study
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. AMNI Stock
  4. 66J Stock
  5. News Amniotics AB